Aceso Life Science Group Limited reported earnings results for the half year ended September 30, 2021. For the half year, the company reported sales was HKD 166 million compared to HKD 194 million a year ago. Net loss was HKD 83 million compared to HKD 434 million a year ago. Basic loss per share from continuing operations was HKD 0.0118 compared to HKD 0.07 a year ago. Diluted loss per share from continuing operations was HKD 0.0163 compared to HKD 0.07 a year ago.